CBD

CBD
Product Description

Pharma Grade CBD API

  • Produced by chemical synthesis;
  • Quality attributesresidual solvents and elemental impurities and in accordance with the ICH guidelines;
  • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies for 1750 mg maximum daily dose, according to ICH Q3A(R2));
  • Storage condition: up to 30oC (stability studies are being conducted in order to address climatic zones I and II, as well as IVB, in accordance with ICH Q1A and ICH Q1B guidelines).
  • DMF prepared in accordance with the M4Q guideline;
  • Technical support for drug product development

Prati, Donaduzzi & Cia Ltda

  • BR
  • 2019
    On CPHI since
Specifications
  • CAS Registry Number
    13956-29-1

Prati, Donaduzzi & Cia Ltda

  • BR
  • 2019
    On CPHI since

More Products from Prati, Donaduzzi & Cia Ltda (2)

  • Cannabidiol

    Product Cannabidiol

    Pharma Grade Cannabidiol API • Produced by chemical synthesis; • Quality attributes, residual solvents and elemental impurities and in accordance with the ICH guidelines; • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies for 1...
  • Cannabidiol oral solution 200mg/mL

    Product Cannabidiol oral solution 200mg/mL

    Product description:
    • Commercial name: Myalo • Indication: Refractory epilepsy • THC FREE • Clinical studies phase III - https://clinicaltrials.gov/ct2/show/NCT02783092?term=prati&rank=1 • Pharmaceutical grade • No interconversion "in vivo" THC • Oral ...